TSH: Why Your "Normal" Thyroid Result Might Not Be Optimal

Why "Normal" TSH Doesn't Always Mean Optimal Thyroid Function

Thyroid-stimulating hormone (TSH) is the pituitary gland's signal to the thyroid: make more T4 and T3. When the thyroid is sluggish, the pituitary turns up the dial and TSH rises. When the thyroid is overactive, the pituitary backs off and TSH falls. It's an elegant feedback loop — but reading a single TSH number in isolation, against a population-wide reference range, misses a lot of clinically important nuance.

Standard laboratory reference ranges for TSH typically run from about 0.45 to 4.5 mIU/L, depending on the assay and the laboratory. That upper limit was derived from large population studies that included participants with undetected subclinical thyroid disease, which statistically skews the "normal" ceiling upward. A 2002 analysis by Surks and colleagues in JAMA Thyroid highlighted that when subjects with thyroid antibodies and other markers of early dysfunction were excluded, the 97.5th percentile of TSH in a truly healthy population dropped to approximately 2.5 mIU/L — a finding that sparked a still-ongoing debate in endocrinology (Surks et al., JAMA 2004; PMID: 14722149).

For people experiencing fatigue, weight gain, cold intolerance, hair thinning, or depression, a TSH of 3.8 mIU/L might be returned as "normal" on a standard lab report — even though functional medicine clinicians and many integrative endocrinologists consider anything above 2.5 mIU/L a sign worth investigating further.

TSH Functional Range 0.5–2.5: What the Research Actually Shows

The concept of a "functional" or "optimal" range reflects the TSH level associated with the lowest risk of symptoms and disease in prospective research — not merely the statistical spread of a population.

Several lines of evidence support the narrower 0.5–2.5 mIU/L target:

• Cardiovascular risk: A prospective cohort study of 25,313 participants published in the Archives of Internal Medicine found that TSH values above 2.5 mIU/L were associated with progressively increasing risk of hypothyroidism over a 10-year follow-up period, suggesting the upper functional threshold has clinical predictive value (Bjøro et al., 2000, referenced in Vanderpump et al., Clinical Endocrinology 1995; PMID: 7489470).
• Pregnancy outcomes: Clinical guidelines from the American Thyroid Association recommend maintaining TSH below 2.5 mIU/L in the first trimester of pregnancy, acknowledging that values even within the "normal" population range carry meaningful risk to fetal neurodevelopment (Alexander et al., Thyroid 2017; PMID: 28056690).
• Mood and cognitive function: A cross-sectional analysis found that within the normal TSH range, individuals with TSH values in the upper tertile (roughly 2.0–4.5 mIU/L) reported significantly more depressive symptoms and worse cognitive performance than those in the lower tertile, independent of overt thyroid diagnosis (Wahlin et al., Psychoneuroendocrinology 2013; PMID: 23434347).
• Bone health: Emerging data suggest low-normal TSH (below 0.5 mIU/L) is associated with reduced bone mineral density, reinforcing that the optimal window is genuinely a range, not a one-directional target (Bauer et al., Journal of Bone and Mineral Research 2001; PMID: 11572162).

Taken together, these studies paint a consistent picture: for most adults who are not pregnant and not on thyroid medication, a TSH between 0.5 and 2.5 mIU/L represents a zone associated with the lowest risk of both underfunction and overfunction. Below 0.5 suggests suppressed thyroid activity or over-replacement; above 2.5 — especially above 3.0 — warrants a closer look at free T4, free T3, and thyroid antibodies (TPO-Ab, TG-Ab).

TSH Interpretation Guide: Reading Your Lab Result in Context

A single TSH number is a starting point, not a complete thyroid assessment. Here's how to layer your interpretation:

What else to order alongside TSH:

• Free T4 (fT4): The primary hormone released by the thyroid; low fT4 with elevated TSH confirms hypothyroidism.
• Free T3 (fT3): The active form. Some people convert T4 to T3 poorly; fT3 can be low even when TSH and fT4 look normal.
• Reverse T3 (rT3): Produced under physiological stress, it competes with active T3 at the receptor level. High rT3-to-T3 ratio can mimic hypothyroid symptoms even with a normal TSH.
• TPO antibodies: Elevated TPO-Ab is the signature of Hashimoto's thyroiditis — the most common cause of hypothyroidism — and can be present years before TSH shifts out of range.
• Thyroglobulin antibodies (TG-Ab): A secondary Hashimoto's marker, useful when TPO-Ab is borderline.

Context also matters: TSH rises naturally with age, follows a diurnal rhythm (highest around 2–4 AM, lowest around 5–6 PM), and is suppressed by caloric restriction, illness, and certain medications including biotin supplementation. Always collect thyroid labs in the morning, fasted, and disclose any supplements to your ordering physician.

Subclinical Hypothyroidism TSH: The Gray Zone Between Normal and Diagnosed

Subclinical hypothyroidism (SCH) is defined as elevated TSH (typically 4.5–10.0 mIU/L) with free T4 still within the normal range. By definition, it's "sub" clinical — meaning symptoms may be mild, absent, or easily attributed to other causes like stress or poor sleep. Yet SCH affects an estimated 3–8% of the general population and up to 15–18% of women over 60.

The treatment debate is genuinely unsettled. A Cochrane systematic review of 21 randomized controlled trials found insufficient evidence to support universal levothyroxine treatment for SCH in non-pregnant adults, particularly when TSH is between 4.5 and 7.0 mIU/L (Feller et al., Cochrane Database 2018; PMID: 29528729). Most endocrinologists reserve pharmacological treatment for individuals with TSH persistently above 10 mIU/L, positive TPO antibodies, or significant symptoms.

For those in the 2.5–7.0 mIU/L gray zone — especially if TPO-Ab positive — the priority becomes:

1. Identifying and correcting nutritional deficiencies that impair thyroid hormone synthesis or conversion
2. Reducing thyroid autoimmune burden where applicable
3. Supporting the HPA axis (adrenal-thyroid crosstalk is bidirectional)
4. Re-testing every 3–6 months to monitor trajectory

This is precisely the population that stands to benefit most from data-driven nutritional support rather than immediately defaulting to pharmaceutical intervention — which is why understanding how thyroid labs connect to your supplement plan matters.

Thyroid Optimal Supplements: Key Nutrients That Support TSH Balance

Several micronutrients are rate-limiting in thyroid hormone synthesis and conversion. Deficiencies in any of them can push TSH upward even in the absence of structural thyroid disease.

Selenium

Selenium is required for the deiodinase enzymes that convert inactive T4 into active T3. A landmark randomized controlled trial in 200 women with Hashimoto's thyroiditis showed that selenomethionine at 200 mcg/day significantly reduced TPO antibody titers and improved thyroid ultrasound echogenicity over 12 months compared to placebo (Gärtner et al., Journal of Clinical Endocrinology & Metabolism 2002; PMID: 11932302). The body cannot store selenium efficiently, and soil depletion makes dietary adequacy unreliable in many regions.

Iodine

Iodine is the elemental backbone of T4 (four iodine atoms) and T3 (three iodine atoms). Both deficiency and excess are problematic: deficiency directly impairs hormone synthesis and raises TSH; excess iodine can trigger autoimmune thyroid reactions (the Wolff-Chaikoff effect). Supplemental iodine should be used conservatively and in the context of selenium adequacy.

Zinc

Zinc participates in the synthesis of thyrotropin-releasing hormone (TRH) and thyroid receptor signaling. Zinc deficiency has been shown to reduce T3 and T4 levels and raise TSH in human observational studies. Repletion with 30 mg/day of zinc in zinc-deficient subjects normalized thyroid hormone profiles in a controlled trial (Nishiyama et al., Journal of the American College of Nutrition 1994; PMID: 8077540).

Vitamin D

Vitamin D receptors are expressed on thyroid cells and on immune cells relevant to autoimmune thyroid disease. Cross-sectional data consistently show lower 25(OH)D levels in Hashimoto's patients compared to healthy controls, and a meta-analysis of 20 studies found significant inverse associations between vitamin D status and TPO antibody levels (Wang et al., Nutrients 2015).

Ashwagandha (KSM-66)

Chronic stress elevates cortisol, which suppresses TSH at the pituitary level and reduces T4-to-T3 conversion peripherally. An 8-week double-blind RCT in subclinical hypothyroid subjects found that KSM-66 ashwagandha at 600 mg/day significantly increased serum T3 and T4 levels and reduced TSH compared to placebo — an effect attributed partly to stress-mediated HPA modulation (Sharma et al., Journal of Alternative and Complementary Medicine 2018; PMID: 28829155).

For a broader look at how adaptogenic herbs interact with the endocrine axis, see our deep-dive on adaptogens and adrenal-thyroid crosstalk.

What This Means for Your Formula

At Ones, the AI health practitioner cross-references your TSH value against your full lab panel — including fT4, fT3, vitamin D, selenium, and zinc status where available — before building a formula recommendation. Rather than treating a number in isolation, the platform looks for patterns: is TSH elevated alongside low selenium? Low vitamin D with positive antibody history? Elevated cortisol with suppressed TSH?

Three Ones ingredients are particularly relevant to TSH optimization:

• Selenium (as selenomethionine, 200 mcg): Matched to the dose used in the Gärtner et al. 2002 Hashimoto's RCT, this is one of the most evidence-backed nutritional interventions for thyroid autoimmunity and T4-to-T3 conversion.
• Zinc (30 mg elemental): Formulated to address the depletion pattern frequently seen in subclinical hypothyroid individuals and those with elevated TPO antibodies.
• Ashwagandha KSM-66 (600 mg): Included when the platform detects elevated stress markers alongside borderline TSH, given the bidirectional HPA-thyroid relationship supported by the 2018 RCT.

Ones also includes a proprietary Thyroid Support blend — a multi-ingredient System Blend combining thyroid-relevant cofactors — which the AI may incorporate into a 6- or 9-capsule daily plan depending on the overall findings and capsule budget.

If your TSH has been flagged as borderline or you're experiencing classic hypothyroid symptoms despite a "normal" result, uploading your lab work to Ones gives you an analysis that goes well beyond the reference range printed on your lab report. You can also explore understanding your full thyroid panel beyond TSH for more context before your next appointment.

Key Takeaways

• The standard TSH reference range (0.45–4.5 mIU/L) was derived from populations that included people with undetected thyroid disease; the optimal functional range is narrower, approximately 0.5–2.5 mIU/L.
• Research links TSH values in the upper half of the "normal" range to higher rates of hypothyroid progression, depressive symptoms, and adverse pregnancy outcomes.
• A complete thyroid assessment includes free T4, free T3, and TPO antibodies — TSH alone cannot confirm optimal thyroid function.
• Subclinical hypothyroidism affects up to 8% of adults and may not require medication, but does warrant nutritional investigation and close monitoring.
• Key nutrients for TSH support include selenium (200 mcg selenomethionine), zinc, vitamin D, and iodine — all of which can be depleted without overt clinical signs.
• Ashwagandha KSM-66 at 600 mg/day showed meaningful improvements in TSH, T3, and T4 in a randomized trial of subclinical hypothyroid subjects, highlighting the adrenal-thyroid connection.
• Always consult a qualified healthcare provider before making changes to thyroid-related supplementation or interpreting your labs for clinical decisions.